Search research articles
Contact Us
Filters
Showing results (281-290 of 296) with videos related to
Page
of 30
Sort By:
RSC Medicinal Chemistry
|
January 22, 2021
Identification of 6-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines with <i>in vivo</i> efficacy against visceral leishmaniasis
Michael G Thomas, Manu De Rycker, Myriam Ajakane, et al.
Nature
|
April 3, 2010
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness
Julie A Frearson, Stephen Brand, Stuart P McElroy, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 10, 2026
Use of a cytochrome P450 humanized mouse model to refine schistosomiasis drug discovery
Sarah D Davey, Josephine E Forde-Thomas, Benjamin J Hulme, et al.
Journal of Medicinal Chemistry
|
June 18, 2016
Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials
Neil R Norcross, Beatriz Baragaña, Caroline Wilson, et al.
Nature
|
July 27, 2018
Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis
Susan Wyllie, Michael Thomas, Stephen Patterson, et al.
ACS Omega
|
February 1, 2021
Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of <i>Mycobacterium tuberculosis</i> Growth
Peter C Ray, Margaret Huggett, Penelope A Turner, et al.
Journal of Medicinal Chemistry
|
December 15, 2021
Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target
Caroline Wilson, Peter Ray, Fabio Zuccotto, et al.
Journal of Medicinal Chemistry
|
August 29, 2017
Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi
Stephen Brand, Eun Jung Ko, Elisabet Viayna, et al.
Journal of Medicinal Chemistry
|
July 28, 2023
Structure-Guided Design and Synthesis of a Pyridazinone Series of <i>Trypanosoma cruzi</i> Proteasome Inhibitors
Michael G Thomas, Kate McGonagle, Paul Rowland, et al.
Nature Communications
|
October 11, 2022
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs
Simon R Green, Susan H Davis, Sebastian Damerow, et al.
Page
of 30
Search research articles
Search
Showing results (281-290 of 296) with videos related to
Sort By:
Page
of 30
RSC Medicinal Chemistry
|
January 22, 2021
Identification of 6-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines with <i>in vivo</i> efficacy against visceral leishmaniasis
Michael G Thomas, Manu De Rycker, Myriam Ajakane, et al.
Nature
|
April 3, 2010
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness
Julie A Frearson, Stephen Brand, Stuart P McElroy, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 10, 2026
Use of a cytochrome P450 humanized mouse model to refine schistosomiasis drug discovery
Sarah D Davey, Josephine E Forde-Thomas, Benjamin J Hulme, et al.
Journal of Medicinal Chemistry
|
June 18, 2016
Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials
Neil R Norcross, Beatriz Baragaña, Caroline Wilson, et al.
Nature
|
July 27, 2018
Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis
Susan Wyllie, Michael Thomas, Stephen Patterson, et al.
ACS Omega
|
February 1, 2021
Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of <i>Mycobacterium tuberculosis</i> Growth
Peter C Ray, Margaret Huggett, Penelope A Turner, et al.
Journal of Medicinal Chemistry
|
December 15, 2021
Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target
Caroline Wilson, Peter Ray, Fabio Zuccotto, et al.
Journal of Medicinal Chemistry
|
August 29, 2017
Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi
Stephen Brand, Eun Jung Ko, Elisabet Viayna, et al.
Journal of Medicinal Chemistry
|
July 28, 2023
Structure-Guided Design and Synthesis of a Pyridazinone Series of <i>Trypanosoma cruzi</i> Proteasome Inhibitors
Michael G Thomas, Kate McGonagle, Paul Rowland, et al.
Nature Communications
|
October 11, 2022
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs
Simon R Green, Susan H Davis, Sebastian Damerow, et al.
Page
of 30